客户经理
Account Executive
**关于Tulip**
制造业占全球经济体的约20%,但仍然是数字化程度最低的行业之一。Tulip在MIT创立,是一个专为一线制造工人设计的AI原生、无代码平台。2026年1月,我们的估值达到13亿美元,并继续实现两位数的同比增长。我们被世界经济论坛评为全球创新者,并被评为Gartner领导者。
**关于日本市场**
日本是全球第四大制药市场,拥有全球最高的制造标准之一。我们认为这是Tulip高度战略性的市场。随着三菱电机的战略投资以及与DMG MORI长期合作的关系,这些关系证明了我们对这个市场的认真承诺。
像阿斯利康、礼来、强生和中外制药这样的全球领先公司已经采用Tulip来实现运营数字化,包括电子批记录、eDHR、生产线清场和偏差管理。
我们现在正在寻找一位能够在此基础上进一步发展的候选人。该职位需要一位能够主动为日本制药和生命科学行业创建销售手册的人选。
工作地点在日本。2026年我们将全面远程办公,计划于2027年开设办公室。请注意,在申请时必须持有有效的日本工作签证。我们无法为该职位提供工作签证担保。
* * *
**该职位位于日本 - 2026年我们将实行远程办公,未来计划于2027年开设办公室。候选人必须在申请时持有有效的日本工作签证。我们无法为该职位提供工作签证担保。**
[Tulip](https://tulip.co/) 将现代技术和人工智能带入制造业。制造业占全球经济体的近20%,每七名地球工作者中就有一人从事该行业,但仍然属于数字化程度最低的领域。十多年前,我们创造了这一类别以弥补这一差距:AI原生软件,将尖端工具直接交到制造前线人员手中。因为我们以人为本、技术狂热,我们正在打造一个未来的工作模式,让人类的创造力与最新技术相结合。
2026年1月,我们成为波士顿少数几家新的AI独角兽公司之一,估值达到13亿美元。我们每年的营收都在两位数增长。世界最好的制造商
查看英文原文
**About Tulip**
Manufacturing accounts for approximately 20% of the global economy, yet it remains one of the least digitized industries. Founded at MIT, Tulip is an AI-native, no-code platform designed for frontline manufacturing workers. In January 2026, we reached a valuation of $1.3 billion and continue to see double-digit year-over-year growth. We have been recognized as a World Economic Forum Global Innovator and a Gartner Leader.
**About the Japanese Market**
Japan is the world's fourth-largest pharmaceutical market and maintains some of the highest manufacturing standards globally. We view it as a highly strategic market for Tulip. Following a strategic investment from Mitsubishi Electric and a long-standing partnership with DMG MORI, these relationships serve as proof of our serious commitment to this market.
Global leading companies such as AstraZeneca, Eli Lilly, J&J, and Chugai Pharmaceutical have already implemented Tulip to digitize operations, including electronic batch records, eDHR, line clearance, and deviation management.
We are now looking for someone to build upon this foundation. This position is for a candidate who can proactively create a sales playbook for the Japanese pharmaceutical and life sciences industry.
The work location is Japan. We will be working fully remotely in 2026, with plans to open an office in 2027. Please note that holding a valid Japanese work visa at the time of application is mandatory. We do not provide visa sponsorship.
* * *
**This role is located in Japan - We are a remote work environment for 2026 with future plans to open up an office in 2027. Candidates must possess a valid Japanese work visa at the time of application. We are unable to provide visa sponsorship for this position.**
[Tulip](https://tulip.co/) brings modern technology and AI into manufacturing. Manufacturing accounts for almost 20% of the global economy and one in every seven workers on Earth, yet remains among the least digitized. More than a decade ago, we created the category to close that gap: AI-native software that puts cutting-edge tools directly in the hands of the people on the manufacturing front lines. Because we are human-centered and tech-obsessed, we are building a future of work where human ingenuity is amplified with the latest technology.
In January 2026 we became one of Boston's few new AI unicorns, reaching a $1.3B valuation. We're growing double digits in revenue year over year. The world's best manufacturers run on Tulip - turning inventory 10x faster, releasing gene therapies in hours instead of weeks, and training master craftspeople to forge engagement rings 5x more rapidly. Headquartered in Somerville, MA with offices in Germany, Hungary, Singapore, Japan, and Israel, we've been consistently named a World Economic Forum Global Innovator, a Gartner leader, and one of Built In Boston's "Best Places to Work."
We run the way we build: AI-forward, humanistic, and high ownership. We're looking for builders who are energized by complex problems, rapid cycles, and the unique opportunity to see their impact on a global scale
**About the Role:**
Japan is the world's fourth-largest pharmaceutical market, home to some of the most demanding manufacturing standards anywhere — and one of Tulip's most strategic markets. Mitsubishi Electric has made a strategic investment in Tulip, and DMG MORI has been a longstanding partner. These relationships reflect how seriously we are committed to this market. Global pharma leaders including AstraZeneca, Eli Lilly, J&J, and Chugai are already running on Tulip to digitize operations — from electronic batch records and eDHR to line clearance and deviation management. The market is real. The customers are real. The foundation is there. What we need now is the person who will build on it. This is a founding role: the first dedicated commercial presence for Tulip in Japan's pharmaceutical and life sciences industry. We're looking for someone who is ready to own it.
**About You:**
- You are on the front lines working with large strategic pharmaceutical, biotech, and life sciences accounts in Japan, presenting from C-suite executives to front-line manufacturing operators and QA leaders.
- You have successfully navigated complex enterprise sales into life sciences companies, with deep understanding of the long deal cycles, multi-stakeholder buying committees, and validation/qualification processes that define this industry.
- Acronyms like ERP, MES, GxP, eBR, eDHR, LIMS, LES, and 21 CFR Part 11 are part of your daily conversations.
- You are used to building, managing, and closing opportunities within a new pipeline — including proof of concept, validation phases, and expansion deals across global pharma networks.
- You are comfortable with ambiguity and eager to contribute to building scalable sales processes and a localized GTM playbook for Japan.
- Experience either working at a startup or helping to develop a new business unit within a multinational company is a plus.
- Genuine, humble, and intellectually curious, with a passion for learning about pharmaceutical manufacturing, regulatory frameworks, and digital transformation.
- Strong customer-centric approach, focused on building long-term relationships with regulated-industry customers.
- Positive, proactive, and collaborative team player.
**What skills do I need?**
- 5+ years selling complex enterprise SaaS solutions into Pharmaceutical, Biotech or broader Life Sciences accounts in Japan, at management and executive levels.
- Demonstrated history of consistently exceeding 100%+ quota, managing a diverse pipeline across multiple types of life sciences customers.
- Experience selling Manufacturing, Quality, and Compliance solutions (MES, eBR/eDHR, LIMS, QMS, or related platforms) is strongly preferred.
- Proven ability to operate and move deals through complex, regulated organizations — including procurement, IT, QA/RA, validation, and operations stakeholders.
- Experience in value-based selling and MEDDPICC, closing large enterprise deals.
- Familiarity with GxP environments, 21 CFR Part 11, computer system validation (CSV), and pharma-specific compliance frameworks.
- Proficient in Salesforce.com, Outreach, ZoomInfo, and LinkedIn Sales Navigator.
- Demonstrated ability to learn new software quickly and speak fluently about SaaS, PaaS, IoT, and cloud solutions.
- Excellent written and verbal communication skills, with the ability to present complex solutions to diverse audiences from operators to C-level in Japanese.
- Strong ability to manage multiple priorities and maintain a high volume of activity.
- Business-level English to communicate with the global team and handle English regulatory and product documentation.
- Native or business-level Japanese to communicate with Japanese customers, internal team, and handle Japanese material.
**Key Responsibilities:**
- Own the full sales cycle in Japan's pharma and life sciences market — prospecting through close — across mid-market and enterprise accounts.
- Build and drive pipeline for complex, regulated deals, navigating multi-stakeholder buying committees (procurement, IT, QA, validation, operations).
- Develop and execute a Japan-specific GTM strategy for pharma/life sciences, owning quarterly and annual revenue targets.
- Present value propositions tied to pharma-specific pain points (batch review, deviation management, audit readiness, paper-based processes), showcasing Tulip's technical and regulatory edge.
- Build relationships across the account — plant managers, QA/RA leaders, digital transformation owners, and C-suite executives.
- Coordinate with channel and consulting partners to co-sell and execute deals.
- Partner with Pre-Sales, Marketing, Customer Success, and Professional Services to ensure smooth, validated implementations and customer success.
- Maintain accurate forecasting and pipeline records in Salesforce, supporting team-wide visibility.
- Track PMDA/FDA/EMA regulatory shifts and competitive dynamics, and serve as the internal voice of the Japan pharma market to shape product, marketing, and GTM priorities.
**Key Collaborators:**
- Business Development Manager
- Solution Engineer
- Marketing
- Professional Services
- Channel & Consulting Partners
**Working At Tulip**
We know even great candidates experience imposter syndrome. Even if you don't match every requirement, applying gives you the opportunity to be considered.
We're building a strong, diverse team that values hard work, families, and personal well-being. Benefits of working with us include:
- Direct impact on product and culture
- Company equity
- Hybrid Work Style
- Learning & Development benefits
- Comprehensive social insurance package (Health, Pension, Employment, and Workers' Compensation)
- Commutation Allowance
We are an equal opportunity employer. At Tulip, we celebrate all. Qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status. Help us build an inclusive community that will transform frontline operations.
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
Please note that we may use AI-based tools to support parts of our hiring process. All data processing is carried out in compliance with local data protection laws, ensuring all personal candidate information is handled securely and ethically.